M C Strach1, B Chakrabarty2, R T Nagaraju3

  • 1Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Faculty of Medicine and Health, The University of Sydney, Darlington, Australia.

ESMO open
|August 25, 2023
PubMed
概括

附录腺癌 (AAs) 是罕见的. 系统化疗显著改善了阳性淋巴结的AA患者的存活率,特别是与细胞还原性手术和高热性腹膜内化疗 (HIPEC) 结合使用时.